Billie Bixby, MD
Pulmonary Disease · Tucson, AZNPI 1770801938
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (43.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Boston Scientific at 47.0% of the total. Reporting peaked in 2019 at $18,104 and has fallen 94.4% since, to $1,011 in 2025. Among pulmonary disease clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $331.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$16K
- Intuitive Surgical$11K
- Steris Corporation$2K
- Pulmonx Corporation$2K
- Johnson & Johnson$1K
- Noah Medical Corporation$903
- plus $2K from 11 others
Across 5 payments — averaging $7447.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$37K
What the payments were for
- Grants$15,00043%
- Travel & lodging$8,58425%
- Food & beverage$5,24515%
- Education$6,00017%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 10 | $16,384 |
| Intuitive Surgical | 34 | $10,561 |
| Steris Corporation | 6 | $1,909 |
| Pulmonx Corporation | 11 | $1,594 |
| Johnson & Johnson | 9 | $1,448 |
| Noah Medical Corporation | 4 | $903 |
| Pinnacle Biologics, Inc | 8 | $736 |
| Veran Medical Technologies, Inc. | 5 | $262 |
| Galvanize Therapeutics, Inc | 2 | $259 |
| Olympus America Inc. | 7 | $216 |
| BD | 2 | $187 |
| Merit Medical Systems Inc | 1 | $119 |
| Baxter Healthcare | 1 | $118 |
| Atricure, Inc. | 1 | $59 |
| Philips North America LLC | 2 | $37 |
| Olympus Corporation Of The Americas | 1 | $26 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - BILIARY DEVICES$15,000
- Da Vinci Surgical System$6,751
- ION$3,000
- TRUFREEZE$1,834
- ZEPHYR ENDOBRONCHIAL VALVE$1,315
- ACQUIRE$901
- GALAXY$823
- MONARCH$772
- Monarch Platform$581
- Photofrin$506
- CHARTIS CATHETER$347
- ZEPHYR DELIVERY CATHETER$347
- PULMONX CHARTIS TABLET CONSOLE$347
- ALIYA SYSTEM$259
- Progel Applicator Spray Tips$160
- GENERAL PULMONARY$138
- Spin$122
- AEROmini Stent and Delivery System$119
- BIG60 Inflation device$119
- Elation Balloon Dilator$119
How this compares
$34,843 in reported general payments places this provider in the 90th percentile of 250 pulmonary disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 59 | $56,541 |
| Spiriva RespimatTiotropium Bromide | 20 | $19,032 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $4,141 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $2,397 |
| Varenicline Tartrate | 12 | $2,383 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 100 | $2,007 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $1,032 |
| Prednisone | 52 | $110 |
| Azithromycin | 36 | $98 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Tucson
- Abhinav MittalTucson$570K
- Sachin ChaudharyTucson$90K
- Todd LocherTucson$25K
- Ravi ChandranTucson$13K
- James KneplerTucson$12K
- Ubair AhmedTucson$10K
- George ParidesMesa$913K
- Rajat WaliaPhoenix$748K
- Brian PorvinPhoenix$276K
- Abid KhokarPhoenix$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.